PRNewsWire
01 May 2026, 00:40 UTC · 22w ago
Verdict
Headline takes no side. We score NKTR −1.00 — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit following the failure of a Phase 2b clinical trial and allegations of misleading statements.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
38m ago
−48.5%
Price agrees with the score
$43.83 vs $85.04 close before publication (Apr 30) · not market-adjusted
NKTR chart →
